Clinical Trials Browser

Phase 3 × INDUSTRY × Metastatic Adenocarcinoma of the Pancreas × Clear all

NCT04083235 2026-03-09

NAPOLI 3

Phase 3 Completed

770 enrolled 13 charts 1 FDA

Gastrointestinal

Metastatic Adenocarcinoma of the Pancreas